image
Healthcare - Biotechnology - NASDAQ - AU
$ 3.487
1.37 %
$ 37.3 M
Market Cap
-2.31
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--0.90%
EBIT Estimate
41.31%
Net Income Estimate
--262.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Alterity Therapeutics Limited
image
ATHE has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ATHE

image
$7.0m$7.0m$6.0m$6.0m$5.0m$5.0m$4.0m$4.0m$3.0m$3.0m$2.0m$2.0m$1.0m$1.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ATHE

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)($18.0m)($18.0m)($20.0m)($20.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ATHE

image
$0.0$0.0($200.0b)($200.0b)($400.0b)($400.0b)($600.0b)($600.0b)($800.0b)($800.0b)($1.0t)($1.0t)($1.2t)($1.2t)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029